Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy A Teft

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Scientific Reports|February 7, 2020
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's diseaseAze Wilson, Ahmed Almousa, Wendy A Teft, et al.
Development Genes and Evolution|October 15, 2013
Developmental competence and the induction of ectopic proboscises in Drosophila melanogasterAnthony Percival-Smith, Lovesha Sivanantharajah, Jacob J H Pelling, et al.
Journal of Personalized Medicine|December 14, 2017
Pharmacogenomics Guided-Personalization of Warfarin and TamoxifenTheodore J Wigle, Laura E Jansen, Wendy A Teft, et al.
Breast Cancer Research and Treatment|April 19, 2014
Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22Simon D Baxter, Wendy A Teft, Yun-Hee Choi, et al.
Breast Cancer Research and Treatment|July 8, 2018
CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapyLaura E Jansen, Wendy A Teft, Rhiannon V Rose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
FcR gamma presence in TCR complex of double-negative T cells is critical for their regulatory functionChristopher W Thomson, Wendy A Teft, Wenhao Chen, et al.
Clinical Pharmacology and Therapeutics|December 9, 2017
Food Effect on Rosuvastatin Disposition and Low-Density Lipoprotein CholesterolCheynne C McLean, Wendy A Teft, Bridget L Morse, et al.
Breast Cancer Research and Treatment|April 23, 2013
Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenograftsInna Y Gong, Wendy A Teft, Justin Ly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligandJoaquín Madrenas, Luan A Chau, Wendy A Teft, et al.
Molecular Pharmaceutics|December 16, 2016
Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux TransportersWendy A Teft, Bridget L Morse, Brenda F Leake, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Scientific Reports|February 7, 2020
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's diseaseAze Wilson, Ahmed Almousa, Wendy A Teft, et al.
Development Genes and Evolution|October 15, 2013
Developmental competence and the induction of ectopic proboscises in Drosophila melanogasterAnthony Percival-Smith, Lovesha Sivanantharajah, Jacob J H Pelling, et al.
Journal of Personalized Medicine|December 14, 2017
Pharmacogenomics Guided-Personalization of Warfarin and TamoxifenTheodore J Wigle, Laura E Jansen, Wendy A Teft, et al.
Breast Cancer Research and Treatment|April 19, 2014
Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22Simon D Baxter, Wendy A Teft, Yun-Hee Choi, et al.
Breast Cancer Research and Treatment|July 8, 2018
CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapyLaura E Jansen, Wendy A Teft, Rhiannon V Rose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
FcR gamma presence in TCR complex of double-negative T cells is critical for their regulatory functionChristopher W Thomson, Wendy A Teft, Wenhao Chen, et al.
Clinical Pharmacology and Therapeutics|December 9, 2017
Food Effect on Rosuvastatin Disposition and Low-Density Lipoprotein CholesterolCheynne C McLean, Wendy A Teft, Bridget L Morse, et al.
Breast Cancer Research and Treatment|April 23, 2013
Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenograftsInna Y Gong, Wendy A Teft, Justin Ly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligandJoaquín Madrenas, Luan A Chau, Wendy A Teft, et al.
Molecular Pharmaceutics|December 16, 2016
Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux TransportersWendy A Teft, Bridget L Morse, Brenda F Leake, et al.
Pageof 3